{
    "authors": [
        {
            "affiliations": [],
            "name": "Abigail K Kois"
        },
        {
            "affiliations": [],
            "name": "Christian M Gill"
        },
        {
            "affiliations": [],
            "name": "David P Nicolau"
        }
    ],
    "id": "SP:90a24be7071dea6feacd44783d82306e31278503",
    "references": [],
    "sections": [
        {
            "text": "Retraction and replacement: Phenotypes, genotypes and breakpoints: an assessment of \u03b2-lactam/\u03b2-lactamase inhibitor combinations against\nOXA-48\n\u00a9 The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com\nTomefa E Asempa, Abigail K Kois, Christian M Gill, David P Nicolau, Journal of Antimicrobial Chemotherapy, 2022, 77 (10): 2622\u201331 https://doi.org/10.1093/jac/dkac074\nSubsequent to the publication of this article, the authors discovered an error in the dose of one of the drugs administered and reported it to the Journal. This required rerunning some of the experiments. Given the circumstances, this article is therefore being retracted. Now that the analysis of the rerun experiments has been completed, the authors have submitted a new version of the article; it has been reviewed and accepted by the editors, and the new version has been republished as https://doi.org/10.1093/jac/dkac425\nD ow nloaded from https://academ ic.oup.com /jac/article/78/3/859/6982770 by Indian Institute of Technology Patna user on 11 January 2024"
        }
    ],
    "title": "Retraction and replacement: Phenotypes, genotypes and breakpoints: an assessment of \u03b2-lactam/\u03b2-lactamase inhibitor combinations against OXA-48",
    "year": 2023
}